Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): A systematic review and meta-analysis

4th World Congress on Infection Prevention and Control

Alaa Badawi and Seung Gwan Ryoo

Public Health Agency of Canada, Canada University of Toronto, Canada

ScientificTracks Abstracts: J Infect Dis Ther

DOI: 10.4172/2332-0877.C1.020

Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) is associated with life threatening severe illnesses and a mortality rate of ~35%, particularly in patients with underlying comorbidities. Systematic analysis of 637 MERS-CoV cases suggests that diabetes and hypertension are equally prevalent in ~50% of the patients. Cardiac diseases and obesity are present, respectively in 30% and 16% of the cases. These conditions down-regulate the synthesis of pro-inflammatory cytokines and impair the host's innate and humoral immune systems. In conclusion, the protection against MERS-CoV and other respiratory infections can be improved if public health vaccination strategies are tailored to target persons with chronic disorders.
Biography

Alaa Badawi is affiliated to the Public Health Agency of Canada, Canada.

Email: alaa.badawi@phac-aspc.gc.ca

Top